Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, formerly known through OMP-131R10, is a novel monoclonal antibody engineered to inhibit granulocyte-macrophage colony-stimulating GM-CSF. Its process of action https://www.targetmol.com/compound/rosmantuzumab